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Abstract
The Saccharomyces cerevisiae succinate dehydrogenase (SDH) provides an excellent model system for studying the
assembly, structure, and function of a mitochondrial succinate:quinone oxidoreductase. The powerful combination of
genetic and biochemical approaches is better developed in yeast than in other eukaryotes. The yeast protein is strikingly
similar to other family members in the structural and catalytic properties of its subunits. However, the membrane domain
and particularly the role of the single heme in combination with two ubiquinone-binding sites need further investigation. The
assembly of subunits and cofactors that occurs to produce new holoenzyme molecules is a complex process that relies on
molecular chaperones. The yeast SDH provides the best opportunity for understanding the biogenesis of this family of iron^
sulfur flavoproteins. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
In this review, we attempt to highlight studies of
the Saccharomyces cerevisiae succinate dehydroge-
nase (SDH) and the contributions those studies
have made to our overall understanding of the suc-
cinate:quinone oxidoreductases (SQOs). We pay par-
ticular attention to the features of the yeast SDH
that di¡erentiate it from other family members and
to observations that extend or challenge our under-
standing of these enzymes.
SDHs and fumarate reductases (FRDs) are com-
plex iron^sulfur £avoproteins with remarkably
similar structural and functional properties [1^5].
They are members of the SQO (EC 1.3.5.1) super-
family, characterized by a catalytic heterodimer
containing covalent FAD and three iron^sulfur
clusters (Fig. 1). Family members catalyze the
interconversion of succinate and fumarate through
reversible oxidation/reduction reactions coupled to
a quinone/quinol species. The catalytic dimer is an-
chored to the surface of energy-coupling membranes
via single or dual hydrophobic subunits. These an-
chor subunits interact with the quinone/quinol spe-
cies, and may contain heme. SDH and FRD will be
used to denote the respective holoenzymes compris-
ing both the catalytic and membrane dimers, while
SQO will be used when referring to both enzymes.
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The mitochondrial SDH is also referred to as com-
plex II [6].
The yeast S. cerevisiae has been a favorite exper-
imental system for studying energy metabolism for
over 100 years. This organism’s ability to rapidly
shift from fermentative to respiratory growth has
been exploited to investigate the regulation and de-
velopment of mitochondrial function [7^11]. SDH is
the only membrane bound enzyme of the tricarbox-
ylic acid cycle, oxidizing succinate to fumarate and
transferring the electrons into the respiratory chain
via ubiquinone. Loss of SDH function in yeast
results in the inability to grow on non-fermentable
carbon sources such as ethanol, glycerol, or lactate.
The puri¢cation and characterization of the yeast
SDH, begun almost 50 years ago, revealed that it
closely resembles its bovine heart counterpart
[12]. Yeast SDH, which can reversibly function
as an SDH or as an FRD, was shown to con-
tain tightly bound £avin and iron [11,12]. Genetic
approaches have served to further reveal SDH struc-
ture and function [13] and its essential role in respi-
ratory growth on non-fermentable carbon sources
[14,15].
The assembly of a mitochondrial protein is a mul-
ti-step process. Many proteins are synthesized as pre-
cursors containing amino-terminal targeting signals
that are removed during or after import [16]. The
polypeptides are transported across the two mito-
chondrial membranes in an unfolded state and often
require the assistance of molecular chaperones to
adopt their proper tertiary and quaternary struc-
tures. Coupled to the folding and oligomerization
of newly synthesized subunits is also a need for co-
factor assembly and insertion. The rami¢cations of
an organellar location discriminate the mitochondrial
enzymes from their prokaryotic counterparts.
Among the ¢ve mitochondrial respiratory chain
complexes, SDH is the only one with all subunits
encoded by the nuclear genome. The other com-
plexes all contain some subunits encoded by mito-
chondrial DNA. This feature, combined with yeast’s
ability to grow fermentatively, permits the appli-
cation of conventional genetic and molecular biolog-
ical approaches to investigate the expression, struc-
ture, function, and biogenesis of the mitochondrial
SQO.
2. Structure of the yeast SDH
The yeast SDH is a heterotetramer that closely
resembles its bovine counterpart in its catalytic and
structural properties and in its £avin and iron^sulfur
cofactor content (Fig. 1) [11,12]. The unlinked genes,
SDH1^SDH4, encode the four SDH subunits in
yeast. Each subunit is made as a precursor protein
possessing an amino-terminal mitochondrial target-
ing sequence that is proteolytically removed after
transport into the organelle. The Sdh1p and Sdh2p
subunits form a catalytic dimer that contains the
active site, the FAD, and three iron^sulfur clusters.
The Sdh3p and Sdh4p subunits are integral mem-
brane proteins that contain heme and the sites of
ubiquinone reduction. The catalytic dimer can oxi-
dize succinate and reduce arti¢cial electron acceptors
without the membrane subunits. These latter are,
however, needed for ubiquinone reduction.
The con¢rmation of the tetrameric structure of the
yeast enzyme relied on a combination of genetic and
biochemical analyses. Mutation in any one of the
four genes leads to the loss of SDH function and
the inability to grow by respiration. The SDH1 and
SDH2 genes were cloned by exploiting the high se-
quence conservation amongst the catalytic subunits
of SQOs [17^22]. With the isolation of the bovine
SDH membrane integral subunits and the demon-
stration of their roles in quinone reduction, it was
presumed that all mitochondrial enzymes would like-
wise be tetrameric [23,24]. When yeast SDH is re-
solved by blue native gel electrophoresis, it migrates
as a major complex of about 150 kDa [25]. Separated
in a second dimension by denaturing gel electropho-
resis, the 150-kDa complex is seen to contain four
subunits, including two small polypeptides that cor-
respond to the membrane subunits, which are clearly
detected [25]. Amino-terminal sequencing of these
two polypeptides allowed the design of degenerate
oligonucleotides and the cloning of the SDH4 gene
[26]. The amino-terminal sequence of the other poly-
peptide facilitated the identi¢cation of the SDH3
gene, which had been cloned by transposon muta-
genesis in a screen to identify genes regulated by
carbon source [27]. Disruption of the SDH3 and
SDH4 genes also results in respiration de¢ciency
and loss of SDH activity [26^28].
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3. The catalytic dimer
3.1. The £avoprotein subunit
The SDH1 gene encodes the £avin-containing sub-
unit. A portion of this gene was ¢rst cloned by de-
signing degenerate oligonucleotides to highly con-
served regions near the covalent FAD attachment
site and the AMP-binding domain [17]. With this
gene fragment, a gene disruption mutant was con-
structed and the entire gene was cloned by comple-
mentation of the resulting respiratory de¢ciency [18].
The SDH1 gene, located on chromosome XI, was
also cloned and disrupted in other studies [19,20].
The protein is made as a precursor of 640 amino
acids (70 185 Da) with a cleavable 28-amino acid
N-terminal targeting sequence [18,19,26]. The se-
quence is 53% and 40% identical with the Escherichia
coli SdhA and FrdA polypeptides, respectively [18].
Loss of the SDH1 gene results in respiration de¢-
ciency, loss of SDH-dependent activities, and the ab-
sence of trichloroacetic acid precipitable £avin [18].
Thus, Sdh1p seems to be the major covalent £avo-
protein in yeast.
The Sdh1p precursor protein contains a targeting
sequence that requires cleavage by two proteolytic
enzymes for maturation. The mitochondrial process-
ing peptidase cleaves the motif Rxs(F/L/I)xx(T/S/
G)xxxx, where the arrow represents the cleavage
site [29]. The remaining eight amino acids form an
octapeptide recognition sequence that is removed by
the mitochondrial intermediate peptidase to leave the
mature subunit. The biological role of the dual cleav-
age event is not understood, but the substrates for
the intermediate peptidase are proteins required for
respiration, mitochondrial protein synthesis, or mito-
chondrial DNA replication [29]. The Sdh3p prese-
quence is also predicted to be cleaved twice.
A closely related gene named SDH1b is found on
chromosome X; the Sdh1bp protein is 84% identical
to Sdh1p [30]. The SDH1b gene is able to fully com-
plement an SDH1 disruption mutant when it is
present on a multicopy plasmid, but respiratory
growth is markedly slower when it is present in single
copy [30]. The integrated SDH1b gene results in less
than 15% of the wild-type succinate-cytochrome c
reductase activity. This ¢nding is consistent with
the measured 100^500-fold lower expression levels
for SDH1b than for the SDH1 gene [30]. It was
concluded that Sdh1bp is unlikely to play an impor-
tant role in mitochondrial respiration [30]. The exis-
tence of Sdh3p and Sdh4p homologs, however (see
below), raises questions as to alternative forms of
SDH that might be present and functionally impor-
tant under speci¢c growth conditions.
The presence of covalently attached FAD in the
yeast SDH has been known for many years [12]. The
mechanism of £avin attachment in relation to SDH
biogenesis is complicated by the need to transport
the precursor protein across both mitochondrial
membranes and to process it. By mutating His-90,
the residue to which the FAD is linked, it was shown
that covalent £avinylation is not required for SDH
assembly to occur, but that it is required for activity
in succinate oxidation [31]. Covalent £avinylation
follows import into the organelle. Pulse-chase experi-
ments demonstrated that the £avin is attached in
vivo after the targeting sequence has been removed
in the matrix [32]. The targeting sequence may ac-
tively prevent £avinylation from occurring, possibly
by impeding the folding of the precursor until it
reaches the matrix [33]. FAD attachment is a post-
translational process requiring the entire polypeptide
and at least a partially folded structure. Flavinyl-
ation can be stimulated in vivo by Sdh2p and with
Krebs cycle intermediates, consistent with an auto-
catalytic reaction [32]. Hsp60 interacts with Sdh1p
but is not required for the £avinylation reaction
[33]. Although the roles of protein transport and
proteolytic processing in £avin attachment remain
to be fully de¢ned, the preponderance of evidence
now suggests that the reaction is autocatalytic for
most covalent £avoproteins [34].
The availability of the three-dimensional structures
of the E. coli and the Wollinella succinogenes FRDs
has led to the identi¢cation of the residues that con-
tact the FAD or the substrate [35,36]. A sequence
alignment makes it clear that the yeast Sdh1p has
identical or similar residues at all these positions.
Unfortunately, for most of these residues, there is
no direct experimental evidence to date with which
to measure the importance of the contact.
3.2. The iron^sulfur subunit
When the yeast SDH2 gene was cloned and the
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predicted protein sequence compared to other mem-
bers of the succinate:fumarate oxidoreductases, con-
siderable sequence conservation was apparent [21,
37]. For example, the human and yeast Sdh2p sub-
units are 71% identical [38]. Sdh2p is a polypeptide
of 266 amino acids (30 229 Da) with a mitochondrial
targeting sequence of about 20 amino acids in length.
Most striking in the Sdh2p sequence are the con-
served clusters of cysteine residues that coordinate
the iron^sulfur clusters. The speci¢c properties of
the clusters in the yeast enzyme, including their redox
potentials, have not been investigated in much depth.
The high level of sequence conservation leaves little
doubt that the clusters are of the same type as in
other family members, although some of the details
may di¡er [32]. Speci¢c studies likely await the pro-
duction of biophysical quantities of puri¢ed enzyme.
The seven amino acids at the extreme C-terminus of
the Sdh2p subunit, containing a Lys^Lys sequence,
are essential for activity and assembly [39]. The C-
terminus of the W. succinogenes FrdB (iron^sulfur)
subunit interacts with several amino acids of its an-
chor subunit and may form essential contacts for
stable membrane association [36]. The crystal struc-
ture of the E. coli Frd shows the C-terminus of the
FrdB subunit interacting with a neighboring Frd
complex; although these interactions may be impor-
tant for crystal packing, it is unlikely that they occur
in vivo [35].
3.3. The catalytic dimer
Sdh1p and Sdh2p form the peripheral membrane-
associated catalytic dimer (Fig. 1). The absence of
one subunit has inevitably led to the absence of the
other suggesting that dimer formation is required for
subunit stability [17,22,39]. It is not clear whether the
yeast catalytic dimer can be stably formed in the
absence of one or both of the membrane anchors.
The pathway of electron transfer in the catalytic
dimer of SDH and FRD enzymes now seems quite
clear. The FRD crystal structures have revealed an
almost linear arrangement of cofactors [35,36]. Elec-
trons £ow from succinate to the FAD, and sequen-
tially through the [2Fe:2S], the [4Fe:4S], and the
[3Fe:4S] clusters. From there, electrons enter the
Fig. 1. Model of the yeast SDH. The Sdh1p and Sdh2p subunits form the catalytic dimer that is anchored to the matrix surface of
the mitochondrial inner membrane by Sdh3p and Sdh4p, integral membrane subunits of the membrane dimer. The FAD cofactor in
Sdh1p is covalently attached to a histidine residue. The £ow of electrons from succinate follows an almost linear chain of cofactors
through the catalytic dimer, including three iron^sulfur (Fe^S) clusters in Sdh2p, to a pair of ubiquinone (Q) molecules in the mem-
brane dimer. The ubiquinone molecule bound to one of these sites is released after reduction to ubiquinol (QH2). The role of the
heme in the membrane dimer has not been elucidated.
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membrane dimer. The reverse direction of electron
£ow operates in FRD enzymes. Not all FRD and
SDH enzymes are freely reversible as seen by the
interesting ‘tunnel-diode’ behavior reported for the
bovine mitochondrial SDH [40]. What are the specif-
ic residues of the catalytic dimer that in£uence this
phenomenon and what biological role does it play?
4. The membrane dimer
Membrane attachment of the yeast SDH catalytic
dimer is mediated by a heterodimer of two hydro-
phobic subunits, Sdh3p and Sdh4p, of 16 675 and
16 638 Da, respectively (Fig. 1) [25,26]. The mem-
brane dimer contains a b-type heme and the active
site for ubiquinone reduction [28,41,42]. Each mem-
brane subunit is predicted, by hydrophobicity analy-
sis, to contain three hydrophobic regions capable of
forming transmembrane helical segments (Fig. 2A,B)
[26,27,43]. Both N-termini are predicted to be ma-
trix-localized because this compartment contains
the peptidase that cleaves the N-terminal targeting
sequences [16]. It is also known that the Sdh1p and
Sdh2p catalytic subunits are anchored to the matrix
face of the inner membrane [1]. There is actually very
little direct experimental evidence that supports the
proposed topologies for the yeast Sdh3p and Sdh4p
subunits. The strongest evidence is the striking struc-
tural conservation among SQOs, which has led to
similar topological models for numerous membrane
anchor subunits [1^3,5].
Unlike the catalytic dimer, which exhibits remark-
able evolutionary conservation in subunit amino acid
sequences and in cofactor composition across spe-
cies, the membrane anchor subunits vary consider-
ably in subunit composition, subunit primary struc-
ture, and in heme content [4,44]. The membrane
subunits are major determinants of the unique prop-
erties of each SDH and FRD enzyme. This is not
surprising since SDH and FRD enzymes from di¡er-
ent sources interact with a variety of di¡erent qui-
none and quinol species [4,44,45]. The speci¢city for
quinone substrates likely dictates the spectrum of
quinone analog inhibitors to which each enzyme is
sensitive [4,44]. The membrane subunits contribute to
establishing the preferred direction of electron £ow
and in so doing de¢ne the enzyme as an SDH or an
FRD enzyme.
The currently accepted model for the membrane
Fig. 2. Topological models of the membrane subunits. Amino acids are represented by the one letter code and transmembrane seg-
ments as cylinders. Selected amino acids discussed in the text are highlighted in black circles. (A) The asparagine at the mature Sdh3p
amino-terminus is exposed after proteolytic removal of the mitochondrial targeting signal. The three Sdh3p transmembrane segments
are referred to as I^III. (B) The leucine at the mature Sdh4p amino-terminus is exposed after proteolytic removal of the mitochondrial
targeting signal. By convention, the three Sdh4p transmembrane segments are numbered IV^VI.
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dimer in all SDH and FRD enzymes has a core of
four anti-parallel helices (Fig. 3). The four-helix bun-
dle model ¢rst proposed by Ha«gerha«ll and Heder-
stedt [44] on the basis of biochemical evidence is
now supported by two crystal structures [35,36]. In
this model, the three transmembrane helices of
Sdh3p are numbered I^III, while the three helices
of Sdh4p are referred to as IV^VI. Transmembrane
helices I, II, IV, and V form an anti-parallel helix
bundle, with helices III and VI ‘dangling’ by the
sides. SQOs with a single membrane subunit having
¢ve transmembrane helices, such as the Bacillus sub-
tilis SDH, ¢t into the model if helix III is removed
and helices II and IV are fused.
Several observations with the yeast SDH suggest
that transmembrane helices III or VI are not dispens-
able and that they may be necessary for providing
rigidity or stability to the helix bundle (Fig. 3). It has
been proposed that helices III and VI may serve as
hydrophobic zippers to stabilize the helix bundle [44].
Our results support this conjecture. Mutations that
truncate Sdh3p or Sdh4p and remove helices III or
VI severely impair respiratory growth and enzyme
activity but do not lead to a complete loss of func-
tion [28,46]. This suggests that helices III and VI are
not required for catalysis but rather play roles in
maintaining the structural integrity of the membrane
dimer. The truncations also cause a greater loss in
enzyme thermal stability than the point mutations
generated in the same studies, suggesting that the
integrity of the helix bundle is a¡ected.
4.1. Heme
The presence of heme in the yeast SDH has long
been a subject of controversy. Based on heme con-
tent and the number of anchor polypeptides, SDH
and FRD enzymes have been classi¢ed into four
types, A^D [4,44]. The yeast SDH and the E. coli
FRD were classi¢ed as D structural subtypes because
they contain two anchor polypeptides but no heme.
The presumed absence of heme in the yeast SDH was
based on an abstract describing the isolation of the
enzyme by cholate solubilization, ammonium sulfate
fractionation, and density gradient centrifugation
[47]. The preparation contained a molar ratio of
heme to £avin of less than 0.2. Additional puri¢ca-
tion by immuno-a⁄nity chromatography further re-
duced the heme to £avin molar ratio to 0.06.
We exploited an unusual property of the heme
(cytochrome b560) in bovine SDH to demonstrate
the presence of stoichiometric amounts of heme in
yeast SDH [42]. Determining the heme content of
membrane bound yeast SDH by using classical dif-
Fig. 3. Structural model of the membrane dimer. The amino- and carboxyl-termini of the Sdh3p and Sdh4p subunits are represented
as N and C, respectively. Transmembrane segments I, II, IV, and V are proposed to associate into a four-helix bundle that forms the
two quinone-binding sites designated QP (proximal) and QD (distal). Residues in ovals are proposed to mediate quinone-binding,
whereas residues in rectangles are involved in intersubunit interactions.
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ference spectra is inappropriate because the more
abundant cytochrome b562 of complex III masks
the heme spectrum. In the bovine SDH, the heme
shows selective oxidation by excess fumarate after
pre-reduction with dithionite [24]. We demonstrated
the presence of a fumarate-oxidizable heme in a di-
thionite-reduced yeast membrane preparation. The
dithionite-reduced minus a dithionite-reduced plus
fumarate-oxidized di¡erence spectrum corresponds
to the absorption spectrum of the heme in SDH
[42,48,49]. The major peak, which appears within
1 min after the addition of fumarate, is symmetrical
and centered at 562 nm and hence is referred to as
cytochrome b562 for yeast SDH. The addition of fer-
ricyanide leads to the reoxidation of cytochromes c
and c1, cytochrome b of complex III, and cyto-
chromes aa3, but the fumarate-oxidized spectrum re-
mains unchanged, suggesting its association with
SDH. We calculated 0.92 þ 0.11 mol of SDH cyto-
chrome b562/mol of covalent FAD, strongly indicat-
ing the presence of a single heme per SDH holoen-
zyme [42]. As would be predicted from this result, the
fumarate-oxidizable spectrum is absent in yeast
strains lacking either the Sdh3p or Sdh4p subunits.
Furthermore, addition of malonate, an SDH-speci¢c
inhibitor that competes with succinate and fumarate
for the dicarboxylate-binding site, abolishes the fu-
marate e¡ect on the di¡erence spectrum.
Two histidine residues have been found to coordi-
nate all SDH hemes investigated [44,50,51]. In the
yeast Sdh3p, His-106 is positioned in the putative
transmembrane helix II and may be such a ligand
(Fig. 2A) [28,44]. Mutagenesis of this histidine does
not eliminate the formation of the SDH cytochrome
b562 [28], but alternative ligands may be used in the
mutant enzyme [52]. The identity of the second heme
ligand is even more perplexing. Cys-78 in the yeast
Sdh4p aligns with the second conserved His that
serves as heme ligand in other SDHs [4,44] and there
are no histidine residues in the vicinity (Fig. 2B).
These sequence alignments suggest that the yeast
SDH may coordinate its heme in an unusual fashion.
Further studies are required to de¢ne the heme li-
gands and the redox properties of the yeast SDH
cytochrome b562.
Unlike the catalytic dimer, where the cofactor
composition is highly conserved, the pathway of elec-
tron transfer through the membrane subunits prob-
ably varies with their cofactor content. Is there a role
for heme in electron transfer from succinate to ubi-
quinone? The E. coli FRD does not contain heme
[35], yet this enzyme is clearly functional in vivo both
as an FRD and as an SDH when expressed aerobi-
cally [53]. Many SDHs contain b-type hemes but the
number and redox properties of these hemes vary
considerably. The B. subtilis SDH contains two b-
type hemes [51], while the E. coli and Ascaris suum
SDHs each contain one [54^56]. In B. subtilis, the
heme with the higher potential (EPm = +65 mV) is
reducible by succinate while the heme with the lower
potential (EPm =395 mV) is not [3]. The heme in E.
coli SDH is fully reducible [56] while that of A. suum
SDH is only partially reduced by succinate [54,55].
Bovine SDH cytochrome b560 is not reducible by
succinate [57]. In B. subtilis SDH, the cytochrome
plays a structural role [3], while the loss of heme
does not impair the assembly of the E. coli enzyme
[50]. The W. succinogenes FRD contains two hemes
that are both likely to participate in electron trans-
port because they are separated by only 4.2 Aî [36].
At present, the role of heme in electron transfer from
succinate to ubiquinone in the yeast SDH is not
clear. Our data indicate that heme may not play an
essential role in quinone reduction. For example, in
membranes of a yeast Sdh4p mutant (K132Q), which
contain only 38% the amount of heme per covalent
FAD as wild-type membranes, we ¢nd 31% succi-
nate-DB (2,3-dimethoxy-5-methyl-6-decyl-1,4-benzo-
quinone) reductase activity [58]. This activity can
be stimulated to 69% by adding excess quinone sub-
strate. The same phenomenon of higher succinate-
DB reductase activity than heme content is also
seen with other Sdh4p mutations that a¡ect heme
assembly (K132E, K132G, and K132V) [58]. This
suggests that heme is not an obligatory carrier during
electron transfer from succinate to ubiquinone. This
is in agreement with the conclusion, reached after
mutagenesis of the heme ligands, that heme is not
necessary for the catalytic function of the E. coli
SDH [50]. However, heme is still detectable in those
heme ligand mutants and thus the role of the heme is
still open to question [52].
Besides a role in electron transport, the heme in
SDH has been implicated in other functions. The
mev-1(kn1) mutation causes a glycine to glutamic
acid substitution two residues from His-73, a pro-
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posed heme ligand in the Caenorhabditis elegans
Sdh3p [59]. The authors postulate that by a¡ecting
the heme environment the stability of a ubisemiqui-
none radical is increased, resulting in the production
of superoxide free radicals [59]. One of the mutations
in the human SDHD gene that causes hereditary
paraganglioma (the development of highly vascular-
ized tumors in the head and neck) is H102L [60].
This histidine is located in an analogous position to
His-71, a heme ligand in the E. coli SdhD [50].
Baysal et al. propose that the heme in SDH may
play a role in oxygen sensing and response to hyp-
oxia in paraganglionic tissue.
4.2. Quinone-binding sites
The coupling of one-electron redox chemistry
(such as in iron^sulfur proteins) to a two-electron
donor/acceptor system (such as quinones) presents
an interesting challenge to biological systems. Elec-
tron transfer must proceed in two discrete univalent
steps with a ubisemiquinone intermediate (Fig. 3).
Many quinone-binding proteins have two quinone-
binding sites, with one site primarily responsible for
stabilizing a ubisemiquinone radical and the quinone
of the other site in dynamic equilibrium with the
quinone pool.
A weak sequence motif used for the prediction of
quinone-binding sites has been described [61]. One of
the more speci¢c variants of the motif is LxxxHxxT,
where x represents any amino acid. The yeast Sdh3p
subunit contains a sequence that closely resembles
this motif : residues 42^49 are LSSLHRIS (Fig.
2A). The serine residue is a conservative substitution
for the threonine of the motif. Residues 42^49 are
found immediately preceding transmembrane helix I
and are in a position analogous to residues of the E.
coli FrdC that are in contact with the menaquinone
[35]. Currently, there is no experimental evidence
supporting a role for this portion of Sdh3p being
involved in quinone interaction. Another sequence
in the yeast Sdh3p, residues 102^109 reads LFAI-
HYGG (Fig. 2A). This sequence is located in the
matrix half of transmembrane helix II. Within this
segment, mutations of Phe-103 and His-106 (dis-
cussed below) a¡ect quinone reductase activity. No
quinone-binding site motif can be readily discerned
in the Sdh4p sequence.
Inhibitors are powerful tools in studying the pro-
tein^quinone interactions that underlie quinone-
mediated electron transfer. The lack of e¡ective in-
hibitors for the yeast SDH has hampered studies of
quinone-binding sites. Several inhibitors are known
to interfere with quinone-binding in many SQOs.
The most commonly used are 2-thenoyltri£uoroace-
tone, 3-methylcarboxin (a carboxanilide), and 2-n-
heptyl-4-hydroxyquinoline-N-oxide. The di¡erential
sensitivities of SDH enzymes to these inhibitors
likely re£ect di¡erences in their quinone-binding
sites. However, none of these molecules is an e¡ec-
tive inhibitor of the yeast enzyme. Carboxin can in-
hibit the yeast enzyme but only at very high concen-
trations; this limits its utility for exploring the
quinone-binding sites by searching for resistant mu-
tants [62].
The 2-alkyl-4,6-dinitrophenol compounds are pro-
tonophore-type uncouplers and potent inhibitors of
all the mitochondrial electron transport complexes
except complex IV, suggesting that they are general
inhibitors of quinone-mediated electron transport
[63,64]. Based on the kinetics of inhibition by
the sec-butyl-4,6-dinitrophenol (s-BDNP) derivative,
two quinone-binding sites have been proposed for
the bovine SDH and the E. coli FRD [63]. s-BDNP
inhibits both enzymes in a non-competitive, biphasic
manner that suggests the presence of two non-equiv-
alent inhibitor-binding sites. One possible explana-
tion for the non-competitive inhibition kinetics by
s-BDNP is that the inhibitor may bind at a site dis-
tinct from the quinone-binding sites but impede elec-
tron exchange between them.
Based on random mutagenesis and inhibitor sensi-
tivity results, we propose a two-site model for qui-
none^protein interactions in the yeast SDH (Fig. 3).
Mutations with speci¢c e¡ects on quinone-binding
are located on opposite sides of the membrane
(Fig. 3) and s-BDNP inhibits yeast SDH with hyper-
bolic, non-competitive kinetics, suggesting the pres-
ence of two non-equivalent inhibitor-binding sites
[41]. By randomly mutagenizing the SDH3 and the
SDH4 genes, we have identi¢ed several amino acid
residues that are required for respiration and qui-
none reduction; for some of these, we could demon-
strate that mutation a¡ects only one s-BDNP-bind-
ing site [28,46]. Those amino acids that selectively
a¡ect the high a⁄nity inhibitor site are clustered
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on the matrix side of the membrane, proximal to the
catalytic dimer [28]. These include His-106 and His-
113 of Sdh3p. Those amino acids that a¡ect the low
a⁄nity inhibitor site cluster on the intermembrane
space side of the membrane [41,46]. These residues
include Phe-69 and Ser-71 of Sdh4p as well as the
Sdh4p C-terminal extension containing Lys-132 (see
below). We believe these two clusters de¢ne the lo-
cations of the proximal (QP) and distal (QD) ubiqui-
none-binding sites in the yeast SDH. The Sdh3p res-
idue Trp-116 is also believed to be at the QP site,
while we consider Sdh4p Lys-132 to be part of the
QD site [28,46,58]. Our data do not currently allow
us to decide which of the two quinone-binding sites
includes Phe-103 (Fig. 3) [28].
The two s-BDNP-binding sites, which have about
a 10-fold di¡erence in a⁄nity for the inhibitor, likely
correspond to or overlap with the two authentic qui-
none-binding sites, QP and QD [28,41,46]. The di¡er-
ence in inhibitor a⁄nity arises from the speci¢c
chemical properties and three-dimensional architec-
tures of the amino acids that form the QP and QD
sites. Amino acid residues found at quinone-binding
sites are mainly of two types [61]. The ¢rst type has
the ability to form hydrogen bonds with the carbonyl
groups of the 1,4-benzoquinone ring; His-113 in
Sdh3p and Ser-71 in Sdh4p may ful¢ll such a role.
The second type of amino acid stabilizes quinone-
binding by interacting with the benzoquinone ring
through ring-stacking interactions. The aromatic
amino acids Phe-103 and Trp-116 in Sdh3p and
Phe-69 in Sdh4p are candidates for such functions.
However, since the substitutions we obtained involv-
ing these residues by random mutagenesis ap-
proaches are not conservative in size or chemical
nature, the speci¢c roles of each of these residues
should be further explored by site-directed mutagen-
esis.
Our data strongly argue for the presence of two
spatially distinct quinone-binding sites in the yeast
SDH (Fig. 3), similar to the E. coli FRD structure
[35]. As discussed above, some amino acid mutations
have di¡erential e¡ects on s-BDNP-binding. The ef-
fects of the Sdh3p W116R mutation on inhibitor-
binding could not be evaluated due to low remaining
quinone reductase activity but its location is consis-
tent with an e¡ect on QP [28]. Similarly, the Sdh3p
mutation F103V speci¢cally a¡ects the enzyme’s af-
¢nity for quinone but inhibitor studies were not per-
formed. Its location near the center is consistent with
a role in either QP or QD. The high a⁄nity s-BDNP-
binding site is close to and may overlap the QP site
while the low a⁄nity s-BDNP site is close to and
may overlap the QD site. Unlike the E. coli FRD,
the yeast SDH possesses a heme that may mediate
electron transfer between the QP and the QD sites.
The fundamental question of why two quinone-bind-
ing sites are utilized remains unanswered. Can ubi-
quinone reduction not be accomplished in a one qui-
none-binding site enzyme?
4.3. The Sdh4p C-terminal extension
The yeast Sdh4p contains a hydrophilic carboxyl-
terminus of about 30 amino acids that extends into
the intermembrane space (Fig. 2B) [41]. A similar C-
terminal extension is not present in any other known
SDH or FRD anchor subunit. Systematic deletion of
the C-terminal extension revealed a role for the ter-
minal 23 amino acid residues (residues 128^135) in
maintaining a conformation necessary for optimal
quinone reduction and enzyme stability. Site-directed
mutagenesis studies further demonstrated the impor-
tance of Lys-132 [58]. However, the complete dele-
tion of the C-terminal extension does not eliminate
respiratory growth, suggesting that it is not directly
involved in the reduction of quinone. Deleting the C-
terminus destabilizes the helix bundle that is the core
of the SDH membrane dimer, rather than directly
a¡ecting quinone interactions. We can speculate
that the Sdh4p C-terminus interacts with intermem-
brane space-localized proteins that can modulate the
catalytic or oligomeric characteristics of the enzyme.
4.4. Interactions between the catalytic and the
membrane dimers
The interactions that allow the membrane dimer to
anchor the catalytic dimer to the membrane surface
have not been explored in depth. In yeast, Asp-117
of Sdh3p and His-99 of Sdh4p are suggested to be at
the anchoring interface of the two dimers because
mutations in these residues propagate speci¢c e¡ects
into the Sdh1p/Sdh2p catalytic dimer (Fig. 3) [28,46].
The D117V and H99L mutations a¡ect the catalytic
dimer by reducing covalent FAD content and the
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turnover number for succinate-phenazine methosul-
fate reductase activity, an activity that does not re-
quire ubiquinone reduction by a membrane dimer.
This strongly suggests that holoenzyme integrity is
compromised due to a structural perturbation of
the anchor subunits that is propagated to the cata-
lytic dimer. The D117V and H99L mutant enzymes
lose the succinate-DB reductase and the succinate-
phenazine methosulfate reductase activities in paral-
lel as they are incubated at elevated temperatures. By
contrast, mutations at residues that speci¢cally a¡ect
ubiquinone-binding, such as Phe-69 of Sdh4p, lead
to thermal instability of the succinate-DB reductase
but not the succinate-phenazine methosulfate reduc-
tase activities.
Asp-117 in Sdh3p is conserved in a large number
of SDH sequences, but is not conserved in the FRD
sequences [44]. The signi¢cance of this observation is
not clear. His-99 of Sdh4p occurs immediately pre-
ceding transmembrane segment III and is not con-
served in other SDH or FRD sequences.
4.5. The Sdh3p and Sdh4p homologs
The Saccharomyces genome database (SGD) con-
tains a homolog for the SDH3 gene called
YMR118c. It is located on chromosome XIII and
encodes a putative mitochondrial membrane protein
(Swiss Protein accession number Q04487) of 196
amino acid residues. Its primary sequence is 57%
identical and 72% similar to the Sdh3p subunit.
SGD also contains two genes (YLR164w and
YOR297c) encoding Sdh4p homologs. The
YLR164w and YOR297c proteins are respectively
52% and 36% identical and 74% and 57% similar
to Sdh4p. YOR297c encodes Tim18p, a newly iden-
ti¢ed subunit of the TIM22 import complex of the
mitochondrial inner membrane. This complex medi-
ates the import of a number of polytopic inner mem-
brane proteins without cleavable presequences
[65,66]. TIM18 (YOR297c) was isolated as a high-
copy suppressor of a temperature-sensitive tim54-1
mutant [65]. Tim18p also co-immunoprecipitates
with Tim54p, Tim22p, and Tim12p [66]. TIM18 mu-
tants are cold-sensitive and respiration competent
[65] and their mitochondria are slower at importing
certain proteins [66]. Genetic evidence also supports
the inclusion of Tim18p as an authentic component
of the import machinery. Disruption of TIM18 is
lethal in TIM54(ts) [65], TIM9(ts), and TIM10(ts)
backgrounds [66]. Multiple copies of SDH4 or
YLR164w do not suppress the temperature-sensitive
TIM54 mutation [65]. Sdh4p and YLR164wp also do
not co-immunoprecipitate with Tim18p. Like Sdh4p,
Tim18p is an integral membrane protein of the inner
membrane with three predicted transmembrane heli-
ces, a matrix-localized amino-terminus and an inter-
membrane space-localized carboxyl-terminus [65,66].
The high sequence identity between Sdh4p and
Tim18p appears to be the only real connection be-
tween these proteins; they appear to be functionally
independent.
Why does S. cerevisiae have multiple genes for
SDH subunits? The homologs do not have a major
role in mitochondrial respiration, since systematic
deletion of these genes has no e¡ect on cell viability
or the ability to grow by respiration [67]. Under our
assay conditions, SDH3 and SDH4 are the only
genes necessary for SDH assembly and function.
However, the homology is too close to be ignored.
The homologs should be tested for their ability to
complement SDH3 and SDH4 mutants. Further-
more, their expression patterns should be investi-
gated. The SDH3 and SDH4 knockout strains
show slow, but visible growth on rich medium con-
taining glycerol as the sole carbon source. It is pos-
sible that one or more of the homologs is expressed
under these conditions and permits this slow growth.
It is interesting to note that YLR164wp has the can-
onical His residue, His-102, which is a potential axial
ligand for heme.
5. Assembly of the yeast SDH
The genetic analysis of respiration de¢cient mu-
tants has led to the identi¢cation of a number of
assembly factors or chaperones needed for the bio-
genesis of the respiratory chain complexes [49,68^77].
At least two gene products have been implicated in
the assembly of SDH [49,78,79].
The ABC1 gene was isolated as a multicopy sup-
pressor of a translation defect in the cytochrome b
mRNA [80]. It encodes a protein of 501 amino acids
having a typical mitochondrial import signal and a
weak sequence similarity to the chaperonin Hsp60
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(16.7% identity to the yeast Hsp60) [80]. Deletion of
the ABC1 gene leads to impaired complex III activity
and the inability to grow on non-fermentable carbon
sources, but the production of cytochrome b with a
normal spectrum. It was suggested that Abc1p is a
chaperone necessary for a late assembly step in com-
plex III biogenesis, but there is no evidence of a
direct interaction between Abc1p and cytochrome b
[80]. Further examination of the ABC1 deletion phe-
notype revealed de¢ciencies in complexes II and IV
[49]. Interestingly, there was a speci¢c loss of almost
90% of the spectrally detectable heme of complex II
with minor losses of total cytochrome b and no loss
of cytochromes aa3. Complexes II, III, and IV are
thermolabile in the absence of Abc1p and their ac-
tivities are lost at elevated temperatures. In contrast
the NADH:quinone or the glycerol-3-phosphate:qui-
none reductase activities are una¡ected by the loss of
Abc1p. The possibility remains that complexes II and
IV undergo structural modi¢cations through an in-
teraction with Abc1p [49]. Alternatively, the e¡ects
on complexes II and IV may be secondary to the
e¡ects on the structure of complex III. There is evi-
dence for the presence of supermolecular complexes
involving SDH in the yeast respiratory chain [81,82].
More recently, a role for Abc1p in ubiquinone
biosynthesis has been demonstrated, although that
role may be indirect [83]. Abc1p is part of a family
of proteins containing motifs found in eukaryotic
protein kinases. This raises the possibility that
Abc1p exerts its e¡ects by regulating a step of ubi-
quinone biosynthesis through the phosphorylation of
a biosynthetic enzyme [83]. Nevertheless, this ¢nding
suggests that ubiquinone has a role in the e⁄cient
biogenesis of SDH. In support of this, loss of the
COQ5 gene, which encodes a methyltransferase in
the yeast ubiquinone biosynthetic pathway, also im-
pairs SDH assembly [84].
The TCM62 gene complements a respiration neg-
ative mutant that was isolated by screening for the
speci¢c loss of succinate but not NADH or glycerol-
1-phosphate oxidase activities [78]. Disruption of the
TCM62 gene leads to dramatic losses of SDH-depen-
dent activities with more minor e¡ects on NADH or
glycerol-1-phosphate dehydrogenase-dependent ac-
tivities. SDH is not assembled in the mutant since
membrane-associated Sdh1p and Sdh2p are not de-
tected. Tcm62p is a mitochondrial protein that is
synthesized with a cleavable amino-terminal target-
ing sequence. The TCM62 gene encodes a 572-amino
acid protein with low but statistically signi¢cant se-
quence identity to members of the Hsp60 family of
molecular chaperones such as the yeast Hsp60
(17.3% identity; 54.4% similarity) and the E. coli
GroEL (16.0% identity; 53.7% similarity). No close
homologs have been identi¢ed, raising the possibility
that Tcm62p function is yeast-speci¢c.
Tcm62p’s role as a chaperone was proposed when
large oligomeric complexes of approximately 200
kDa containing both Tcm62p and SDH subunits
were resolved by blue native gel electrophoresis
[78]. However, SDH is more abundant than is the
chaperone and can also be detected as a Tcm62p-
free complex of approximately 130 kDa. When
Tcm62p is overexpressed, it forms insoluble protein
aggregates within the mitochondria; these aggregates
trap Sdh1p and Sdh2p subunits but not unrelated
proteins such as Hsp60 or the L-subunit of the
ATP synthase. These observations suggest that
Tcm62p speci¢cally interacts with at least two SDH
subunits. Interestingly, in the absence of SDH,
Tcm62p was found as a slower migrating complex
of an estimated mass of 450 kDa. It was speculated
that this latter complex might be a heptameric ring-
like structure resembling the E. coli GroEL [85], but
there is no evidence for this.
It is unusual that a single transmembrane segment
is predicted within Tcm62p including residues 469^
491 [78]. Members of the Hsp60 family are not nor-
mally membrane-associated. In GroEL, the center of
the analogous region (residues 435^457) contains
three additional charged residues making this a
much more hydrophilic helix. The proposed trans-
membrane segment of Tcm62p contains some polar
residues but these may function to stabilize interac-
tions between monomers [86]. The localization of
Tcm62p as a membrane protein was demonstrated
by the accessibility of the C-terminus to proteinases
in the intermembrane space, by the need for deter-
gents in solubilization, and by resistance to solubili-
zation by salt and urea. Tcm62p demonstrates only
partial resistance to solubilization by alkaline sodium
carbonate, pH 10.5. It is di⁄cult to envisage how
Tcm62p could adopt the double heptameric ring
structure of GroEL if it is truly integrated into the
membrane. On the other hand, the mammalian mi-
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tochondrial Hsp60 is fully functional in protein fold-
ing as a single ring [87,88] and GroEL can be con-
verted to a partially functional single ring chaperone
by mutagenesis [89].
Recently Tcm62p was found by gel ¢ltration in a
large complex of molecular mass of approximately
850 kDa, similar in size to the Hsp60 complex [79].
The Sdh2p subunit was not detected in this complex.
These authors localized Tcm62p as a soluble protein
of the mitochondrial matrix. Mutants with a dis-
rupted TCM62 gene were temperature-sensitive for
growth on non-fermentable carbon sources and this
was ascribed to increased thermosensitivity of the
mitochondrial protein synthesis machinery. Var1p,
a ribosomal subunit, accumulated as an insoluble
aggregate at elevated temperatures in the absence
of Tcm62p. Thus, Tcm62p has the additional role
of protecting mitochondrial translation under heat
stress. A similar role has recently been demonstrated
for Fmc1p in the assembly of the F1-ATPase at high
temperatures [77].
The discrepancies in the physical properties as-
cribed to the Tcm62p protein in the two studies dis-
cussed above need to be addressed [78,79]. The pro-
tein characterized in our lab had been epitope-tagged
at its C-terminus; perhaps the additional protein se-
quence interferes with targeting and/or assembly. It
remains to be determined which steps of the SDH
assembly pathway require assistance of a chaperone.
Even more puzzling is why the yeast complex might
require this assistance, while the SDHs of other or-
ganisms (which do not have counterparts to Tcm62p)
do not. Whether other substrates require Tcm62p
function at elevated temperatures also remains to
be determined.
The generation of iron^sulfur clusters is an essen-
tial function of yeast mitochondria [90]. This process
is a complex one involving at least 10 gene products
[90]. As might be expected, mutations in many of
these proteins lead to a loss of SDH, probably due
to the structural instability of the Sdh2p subunit and
of the catalytic dimer. For example, in the absence of
Nfs1p, a cysteine desulfurase, SDH activity is rapidly
lost and the subunits are degraded [91,92]. Mutations
in the chaperone proteins Ssq1p (an Hsp70-type
chaperone) and Jac1p (a 22-kDa co-chaperone that
may regulate Ssq1p) also lead to loss of SDH activ-
ity, suggesting they may play a role in the assembly
or repair of iron^sulfur clusters [93]. The Isa1p and
Isa2p proteins contain conserved cysteine residues
that are necessary for their function. They may
participate in the assembly of cluster intermediates
in preparation for their eventual transfer to the
apoprotein acceptors [90,94,95]. The insertion of
iron^sulfur clusters into Sdh2p is an intriguing bio-
logical process. When and how are the clusters in-
serted into Sdh2p? Are chaperones required to main-
tain the protein in a state competent for cluster
insertion?
6. Regulation of SDH expression
In yeast, the expression of the enzymes of oxida-
tive phosphorylation is repressed by glucose [5].
Transcriptional regulation has been investigated for
all the SDH genes [21,27]. The SDH2 promoter con-
tains CCAAT boxes, which are targets of the nuclear
HAP2/3/4 complex, a transcriptional activator with
high activity in the presence of non-fermentable car-
bon sources [5]. The SDH2 promoter is activated 3^
4-fold in the absence of glucose [5]. The SDH1 and
SDH3 genes were cloned in a screen to isolate genes
regulated by HAP2 but also require HAP3 and
HAP4 for maximal expression [27]. Both SDH1
and SDH3 are expressed about 5-fold more strongly
on galactose than on glucose as judged by L-galac-
tosidase fusion studies [27]. The SDH4-derived
mRNA is also more abundant on galactose-contain-
ing medium [27]. Thus, it would appear that all four
genes are similarly induced at the level of transcrip-
tion.
The glucose-regulated turnover of the SDH1 and
SDH2 mRNAs has been observed and characterized
[96^98]. SDH1 and SDH2 mRNA levels drop more
than 10-fold within minutes of the addition of glu-
cose. The 5P untranslated region is the most signi¢-
cant cis-acting element in SDH2 mRNA instability
and can render another message unstable in the pres-
ence of glucose [5]. The turnover of the SDH3 and
SDH4 messages has not been investigated. The reg-
ulation of SDH expression is thus controlled by both
transcriptional and post-transcriptional mechanisms,
although the reason for the rapid degradation of the
SDH1 and SDH2 messages following glucose addi-
tion is not clear [5].
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7. Future directions
Although our understanding of the structural and
catalytic properties of the SQOs has been greatly
improved through analysis of the high-resolution
crystal structures [35,36], there are still many ques-
tions remaining. Here we will focus on the questions
that pertain most to the mitochondrial enzymes.
The assembly of the mitochondrial SDHs is com-
plicated because of the need to coordinate the trans-
port and processing of newly synthesized subunits
and cofactors. At least in the case of S. cerevisiae,
there appears to be a chaperone (Tcm62p) with a
major role in the assembly of the enzyme. Is yeast
the only organism to have this chaperone? To date,
no close Tcm62p homologs are present in the data-
bases. What property of the yeast SDH dictates the
requirement for Tcm62p? How does Abc1p partici-
pate in the biogenesis of SDH?
The SDH and FRD enzymes are rich in cofactors.
When and how are these cofactors inserted? Are dis-
crete intermediates such as catalytic or membrane
dimers formed during enzyme assembly? What are
the speci¢c interactions that must occur between
the membrane and catalytic dimers to create an e⁄-
cient, stable electron-transporting holoenzyme? A
combination of biochemical and genetic approaches
will likely be most productive in answering these
questions.
The presence of closely related homologs for at
least three of the yeast SDH subunits is intriguing.
Do any of the homologs function in respiration and
under what conditions do they do so? Are multiple
genes, which may be expressed in a tissue-speci¢c
manner, used in other organisms to tailor the cata-
lytic or structural properties of the enzyme to speci¢c
cellular demands or conditions?
The role of the heme in electron transfer is a key
question that needs to be addressed. In yeast, de¢n-
ing the heme ligands must be a ¢rst step. Analyzing
the relationship between quinone-binding sites and
the heme will surely clarify the mechanism of elec-
tron transport in the enzyme. The heme may also
have additional roles beyond electron transport.
There is circumstantial evidence that the heme in
mitochondrial SDH may play a role in signaling
the mitochondrial energy state to the nucleus [60].
Is a direct or an indirect signaling mechanism in-
volved? How do mutations in SDH subunits a¡ect
the signaling?
SDH may also be a generator of toxic oxygen free
radicals, which are thought to contribute to the de-
terioration of mitochondrial function with age [59].
The reduction of quinones following electron trans-
port through iron^sulfur clusters results in ubisemi-
quinone radicals. The stability of these radicals can
be modulated by changing the protein environment
surrounding the ubisemiquinone [99]. It is necessary
to stabilize the ubisemiquinone radical to allow the
reduction of quinone in two one-electron steps. A
less stable ubisemiquinone species may increase the
probability of electron transfer to molecular oxygen
and the formation of superoxide radicals. Under-
standing the architecture of the quinone-binding sites
in more detail and the role of the heme in ubisemi-
quinone formation, stabilization, and reduction will
be important avenues of research. The carboxyl-ter-
minal extension of the Sdh4p subunit, with its role in
the formation of quinone-binding sites, appears to be
unique to the yeast enzyme; how is its function re-
placed in other enzymes? The E. coli FRD can also
produce superoxide when shifted to an aerobic envi-
ronment but the evidence suggests that the £avin is
the direct electron donor to oxygen [100]. The role of
the £avin in free radical generation by SDH enzymes
should be further investigated. The in£uence of SDH
inhibitors and mutations on the generation of free
radicals also needs to be considered.
Many of the problems we discuss above would
bene¢t from the development of an e⁄cient protocol
for purifying the yeast SDH. Puri¢ed protein could
also be used to characterize in detail the redox prop-
erties of the cofactors. Few e¡orts at puri¢cation
have been reported. We have attempted to overex-
press the enzyme, but the complexities of the enzyme
structure and of its assembly pathway make this a
di⁄cult undertaking. The use of a⁄nity tags may
facilitate the endeavor. The yeast system with its
powerful genetic potential can be instrumental in de-
ciphering the complexities of the mitochondrial
SDH.
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